DAPK1 and Alzheimer disease: In human AD samples and hTau mouse models, the expression and enzymatic activity of DAPK1 were found to be upregulated, respectively, resulting in a reduction in SENP1 protein levels in the hippocampus (Figs. 11 and S9).